Loading...
Backup Documents 03/24/2026 Item #16D 3 ORIGINAL DOCUMENTS CHECKLIST & ROUTING SLIP TO ACCOMPANY ALL ORIGINAL DOCUMENTS SENT TO 3.24.26 BCC MTG THE BOARD OF COUNTY COMMISSIONERS OFFICE FOR SIGNATURE De 7, Print on pink paper. Attach to original document. The completed routing slip and original documents are to be forwarded to the County Attoly�f at the time the item is placed on the agenda. All completed routing slips and original documents must be received in the County Attorney Office no later than Monday preceding the Board meeting. **NEW** ROUTING SLIP Complete routing lines#1 through#2 as appropriate for additional signatures,dates,and/or information needed. If the document is already complete with the exception of the Chairman's signature,draw a line through routing lines#1 through#2,complete the checklist,and forward to the County Attomey Office. Route to Addressee(s) (List in routing order) Office Initials Date 1. Carolyn Noble Community and Human CN 3/18/2026 Services 2. County Attorney Office— County Attorney Office iiinL 3/ / 3. COvn{y / ti q G! Cs rt sstoTfers 4. Minutes and Records(( tJ Clerk of Court's Office (4)1:7 PRIMARY CONTACT INFORMATION Normally the primary contact is the person who created/prepared the Executive Summary. Primary contact information is needed in the event one of the addressees above,may need to contact staff for additional or missing information. Name of Primary Staff Carolyn Noble Phone Number 239-252-5321 Contact/ Depaitalent Agenda Date Item was 3/24/2026 Agenda Item Number 16.D.3. Approved by the BCC Type of Document PARTICIPATION FORM Number of Original 1 Attached Documents Attached PO number or account number if document is to be recorded _ INSTRUCTIONS & CHECKLIST Initial the Yes column or n''rk"N/A" in the Not Applicable column,whichever is Yes N/A(Not appropriate. (Initial) Applicable) 1. Does the document require the chairman's original signature STAMP OK CN 2. Does the document need to be sent to another agency for additional signatures? If yes, N/A provide the Contact Information(Name;Agency;Address;Phone)on an attached sheet. 3. Original document has been signed/initialed for legal sufficiency. (All documents to be Yes signed by the Chairman,with the exception of most letters,must be reviewed and signed by the Office of the County Attorney. 4. All handwritten strike-through and revisions have been initialed by the County Attorney's N/A Office and all other parties except the BCC Chairman and the Clerk to the Board 5. The Chairman's signature line date has been entered as the date of BCC approval of the N/A document or the foal negotiated contract date whichever is applicable. 6. "Sign here"tabs are placed on the appropriate pages indicating where the Chairman's YES signature and initials are required. 7. In most cases(some contracts are an exception),the original document and this routing slip N/A should be provided to the County Attorney Office at the time the item is input into SIRE. Some documents are time sensitive and require forwarding to Tallahassee within a certain time frame or the BCC's actions are nullified. Be aware of your deadlines! _ 8. The document was approved by the BCC on above date and all changes made during islno the meeting have been incorporated in the attached document. The County an option for Attorney's Office has reviewed the changes,if applicable. this line:, 9. Initials of attorney verifying that the attached document is the version approved by the s/A is not BCC, all changes directed by the BCC have been made,and the document is ready for the an,option for,, • Chairman's signature. this line) 16D3 EXHIBIT G 1iix (Q)Remnant l>cfeudants' (:onthin&d SuhdiN ision Participation and Release Lorna ("Combined Participation Form") Governmental Entity A rCOLLIER COUNTY State:FL Authorized Official: Amy Patterson Address 1: 3299 Tamiami Trail h Address 2: Suite 202 City, State,Zip: Naples,PL .4112 Phone: 239-252-8383 Email: amy.patterson@collier.gov The governmental entity identified above ("Governmental Entity"), in order to obtain and in consideration for the benefits provided to the Governmental Entity pursuant to the six (6) Remnant Defendants' Settlement Agreement ("RDSA"), dated February 3, 2026, and described further in Paragraph 1, and acting through the undersigned authorized official, hereby elects to participate in the RDSA, release all Released Claims against all Released Entities, and agrees as follows: I. The Governmental Entity hereby elects to participate in the RDSA as a Participating Subdivision with each of the following six (6) Remnant Defendants that are parties to the RDSA: (1) Associated Pharmacies, Inc. (and American Associated Pharmacies), (2) J M Smith Corporation, (3) Morris and Dickson Co., L.L.C., (4) Louisiana Wholesale Drug Company, Inc., (5) North Carolina Mutual Wholesale Drug Company, Inc., and (6) United Natural Foods, Inc. (and SuperValu). 2. The Governmental Entity is aware of and has reviewed the RDSA, understands that all capitalized terms not defined in this Combined Participation Form have the meanings defined in the RDSA, and agrees that by executing this Combined Participation Form, the Governmental Entity elects to participate in the RDSA and become a Participating Subdivision as provided in the RDSAs. 3. The Governmental Entity shall promptly, and in any event no later than 14 days after the Reference Date and prior to the filing of the Consent Judgment. dismiss with prejudice any Released Claims that it has filed against any Released Entity in the RDSA. With respect to any Released Claims pending in In Re National Prescription Opiate Litigation, MDL No. 2804, the Governmental Entity authorizes the Plaintiffs' Executive Committee to execute and file on behalf of the Governmental Entity a Stipulation of Dismissal with Prejudice for each of six (6) Remnant Defendants listed in Paragraph 1 above substantially in the form found at https://natianalopioidsettlement.com/additional- settlements/. 4. The Governmental Entity agrees to the terms of each of the RDSA pertaining to Participatin G-1 Cl alp Ir`r tikAt 1603 Subdivisions as defined therein. 5. By agreeing to the terms of the RDSA settlements and becoming a Releasor, the Governmental Entity is entitled to the benefits provided therein, including, if applicable, monetary payments beginning after the Effective Date. 6. The Governmental Entity agrees to use any monies it receives through the RDSA solely for the purposes provided therein. 7. The Governmental Entity submits to the jurisdiction of the MDL Court and agrees to follow the process for resolving any disputes described in the RDSA. 8. The Governmental Entity has the right to enforce the RDSA as provided therein. 9. The Governmental Entity, as a Participating Subdivision, hereby becomes a Releasor for all purposes of the RDSA. including without limitation all provisions related to release of any claims, and along with all departments, agencies, divisions, boards, commissions, districts, instrumentalities of any kind and attorneys, and any person in his or her official capacity whether elected or appointed to serve any of the foregoing and any agency. person, or other entity claiming by or through any of the foregoing, and any other entity identified in the definition of Releasor, provides for a release to the fullest extent of its authority. As a Releasor, the Governmental Entity hereby absolutely, unconditionally, and irrevocably covenants not to bring, file, or claim, or to cause, assist or permit to be brought, filed, or claimed, or to otherwise seek to establish liability for any Released Claims against any Released Entity in the RDSA in any forum whatsoever. The release provided for in the RDSA is intended by the Parties to be broad and shall be interpreted so as to give the Released Entities in the RDSA the broadest possible bar against any liability relating in any way to Released Claims and extend to the full extent of the power of the Governmental Entity to release claims. The RDSA shall be a complete bar to any Released Claim against the Released Entities. 10. The Governmental Entity hereby takes on all rights and obligations of a Participating Subdivision as set forth in the RDSA. 11. In connection with the releases provided in the RDSA, each Governmental Entity expressly waives, releases, and forever discharges any and all provisions, rights, and benefits conferred by any law of any state or territory of the United States or other jurisdiction, or principle of common law, which is similar, comparable, or equivalent to § 1542 of the California Civil Code, which reads: General Release; extent. A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release that, if known by him or her would have materially affected his or her settlement with the debtor or released party. G-2 0 �0 o CE` 1603 A Releasor may hereafter discover facts other than or different from those which it knows, believes, or assumes to be true with respect to the Released Claims in the RDSA, but each Governmental Entity hereby expressly waives and fully, finally, and forever settles. releases and discharges, upon the Effective Date, any and all Released Claims that may exist as of such date but which Releasors do not know or suspect to exist,whether through ignorance. oversight, error, negligence or through no fault whatsoever, and which, if known, would materially affect the Governmental Entities' decision to participate in the RDSA. 12.The Governmental Entity understands and acknowledges that nothing herein is intended to modify in any way the terms of any of the RDSA, to which Governmental Entity hereby agrees. To the extent this Combined Participation Form is interpreted differently from the RDSA in any respect, the RDSA controls. I have all necessary power and authorization to execute this Combined Participation Form on behalf of the Governmental Entity. Signature: Name: Amy Patterson Title: County Manager Date: (5` 6" /�&' L. Appro .d 6 and legality Jeffrey .?thtzkow County Attorney G C.1V2 DS 1 I 16 3. To: COLLIER COUNTY, FL Reference Number: CL-2023107 NOTICE OF NEW NATIONAL OPIOID SETTLEMENT AND UPCOMING ACTION NEEDED TO PARTICIPATE: MONDAY, May 4, 2026, DEADLINE A new national opioid settlement has been reached with six regional distributors/dispenser defendants (Remnant Defendants Settlement): Associated Pharmacies, Inc. (and American Associated Pharmacies); J M Smith Corporation; Louisiana Wholesale Drug Company, Inc.; Morris and Dickson Co.; North Carolina Mutual Wholesale Drug Company, Inc.; and United Natural Foods, Inc. (including is subsidiaries SuperValu and Advantage Logistics) (Six Remnant Defendants). This is the formal Notice required by the Remnant Defendants Settlement. You are receiving this Notice because your entity is entitled to participate (Eligible Entity). Please read this Notice and the attached Settlement Overview carefully. The Settlement Overview provides additional information concerning this new national opioid settlement. Your entity may have participated in prior national opioid settlements. This Notice concerns the opportunity to participate in this new settlement with the Six Remnant Defendants. Your entity may participate in this new settlement even if it did not participate in a prior national settlement. All Eligible Entities must "opt in" to participate in this new settlement. To do so, a person with authority must sign and return the Combined Subdivision Participation and Release Form that will be sent via DocuSign shortly. If an Eligible Entity is unable to return an executed Combined Subdivision Participation and Release Form using DocuSign, the signed Combined Subdivision Participation and Release Form may be submitted via the Rubris Platform Portal. Please utilize the link included in this Notice to upload your entity's Combined Subdivision Participation and Release Form directly to the Rubris Platform Portal. DocuSign remains the preferred method of submission of the needed form. The deadline to return the Combined Subdivision Participation and Release Form is Monday, May 4, 2026. Questions about this Notice or the process for receiving and submitting the required Combined Subdivision Participation and Release Form may be directed to your attorney or the Notice and Claims Administrator at opioidsparticipation@rubris.com. Please review the list of individuals on this email and contact the Notice and Claims Administrator at opioidsparticipation@rubris.com if someone else at your entity should receive communications about this Settlement. 182893373.1 0 'o'. 6 a 3 ry If your entity is represented by an attorney with respect to opioid claims and they are not copied on this message, please immediately contact them concerning this Notice. Thank you, National Opioids Notice and Claims Administrator for the Remnant Defendants Settlement The Notice and Claims Administrator is retained to provide the Settlement Notice required by the Settlement Agreement referenced above and to manage the collection of Subdivision Settlement Participation Forms. 182893373.1 Edn National Opioids Settlements: Six Remnant Defendants 1 6 0 3 Notice and Claims Administrator opioidsparticipation@rubris.com To: COLLIER COUNTY, FL Reference Number: CL-2023107 THIS SETTLEMENT OVERVIEW CONTAINS IMPORTANT INFORMATION ABOUT THE SIX REMNANT DEFENDANTS NATIONAL OPIOID SETTLEMENT SIX REMNANT DEFENDANTS SETTLEMENT OVERVIEW A new national opioid settlement has been reached with six regional distributors/dispenser defendants (Remnant Defendants Settlement): Associated Pharmacies, Inc (and American Associated Pharmacies); J M Smith Corporation; Louisiana Wholesale Drug Company, Inc.; Morris and Dickson Co.; North Carolina Mutual Wholesale Drug Company, Inc.; and United Natural Foods, Inc. (including its subsidiaries SuperValu and Advantage Logistics) (Six Remnant Defendants). There is one settlement agreement covering the combined settlement with the Six Remnant Defendants. If effectuated, the proposed Remnant Defendants Settlement will result in the the Six Remnant Defendants paying a combined $97,625,000.00 in cash for purposes of abating the opioid epidemic. An Eligible Entity's participation in the Remnant Defendants Settlement, the Settlement will result in a one-time settlement payment to each Eligible Entity. The Settlement funds must be used for the Core Strategies and Approved Uses set forth in Exhibit D of the Remnant Defendant Settlement Agreement. The Remnant Defendants Settlement does not include State Attorneys General or any amount allocated to a State. Rather, this Settlement will be distributed only and directly to any Eligible Entity that participates by signing and returning the Combined Subdivision Participation and Release Form by the deadline. The allocation to participating entities will be calculated using the national Denver model but removing from the equation any amount that the Denver model would allocate to a State Attorney General or a State allocation. Specifically, the interstate allocation formula will be used to calculate what amount should go to all the subdivisions in each state and then apply the intrastate allocation as between all subdivisions who are either a litigating subdivision or a non-litigating subdivision with a population of 30,000 or more. Using that methodology, a national pro-rata percentage was created. That allocation percentage of participation is reflected in Exhibit E of the Remnant Defendant Settlement Agreement. 182891755.1 o � 6 3 Eligible Entities must decide whether to participate by Monday, May 4, 2026. WHO IS RUBRIS INC. AND WHAT IS THE NOTICE AND CLAIMS ADMINISTRATOR? The Settlement provides that a Notice and Claims Administrator will provide notice and manage the collection of participation forms. Rubris, Inc. is the Notice and Claims Administrator for this new Settlement and was also retained for the prior national opioid settlements. WHY IS YOUR ENTITY RECEIVING THIS NOTICE? Your entity is eligible to participate in this Settlement. This Notice is also sent directly to counsel for each Eligible Entity if the Notice and Claims Administrator has their information. If you are represented by an attorney with respect to opioid claims, please contact them. WHERE CAN YOU FIND MORE INFORMATION? Detailed information about the Settlement may be found at: https://nationalopioidsettlement.com You are encouraged to review the Settlement Agreement terms and discuss the terms and benefits with your counsel. Each Eligible Entity will need to decide whether to participate in the proposed Settlement, and entities are encouraged to work through this process before the Monday, May 4, 2026, deadline. HOW DO YOU PARTICIPATE IN THE SETTLEMENT? The Settlement requires that each Eligible Entity take affirmative steps to "opt in" to the Settlement. You will receive the Combined Subdivision Participation and Release Form via DocuSign along with instructions from the Implementation Administrator. In order to participate in this Settlement, a person with authority must sign and return the required Combined Subdivision Participation and Release Form. DocuSign remains the preferred method of submission of the needed form. The participation rate will be used to determine whether participation for each Remnant Defendant is sufficient to move forward. If the Settlement moves forward, your release will become effective as to that Remnant Defendant. If the settlement as to any Remnant Defendant does not move forward, the release as to that Remnant Defendant will not become effective. Please add the following email addresses to your "safe" list so emails do not go to spam / junk folders: dse na3ga docusign.net and opioidsparticipation@rubris.com. Please monitor your email for the Participation Form and instructions. • o :o 182891755.1 O ;n 16p3 All required documentation must be signed and returned on or before Monday, May 4, 2026. Upon effectuation of the Remnant Defendants Settlement, each Eligible Entity will be provided with a link to a portal where you will enter contact and payment information to receive settlement funds. El -rtu 182891755.1 E '.o